Dassault Systèmes agreed to buy Arisglobal for up to $2 billion as it strengthens its position in the life sciences sector, advancing its ambition to create a unified AI intelligence platform for the industry where datasets are currently fragmented. Triumph-2 also included a 4-mg dose showing weight loss of 12.7%. Developing an HIV vaccine, one small step at a timeThe HIV vaccine field is increasingly focusing on inducing broadly neutralizing antibodies that can recognize the virus’s genetic diversity. Several studies published in 2025 and 2026 how these designs guide antibody maturation in humans and generate broad neutralizing responses in nonhuman primates, although no HIV vaccine has yet demonstrated protective efficacy in large clinical trials. The appellate court decision will shut down efforts by Bristol Myers Squibb Co., Eli Lilly and Co., Johnson & Johnson and Novartis to move to a rebate system – at least for now.